Mettez-vous hors ligne avec l'application Player FM !
The Unwavering Journey: To Jerusalem
Manage episode 442741258 series 1319708
In this episode, Dr. John points us to Luke 9:51, where Jesus "set His face to go to Jerusalem." This moment marks a crucial turning point in Jesus' ministry. Even in the face of opposition, Jesus remained steadfast in His journey toward the cross. Dr. John highlights how this decision by Jesus serves as both a challenge and an encouragement for us to remain faithful to God’s calling, even when the road ahead is difficult.
The Unwavering Journey: In this series of messages, Dr. John unpacks Luke 9-13, exploring Jesus’ unwavering journey as He sets his face toward Jerusalem, fully aware of the sacrifice ahead. With every step, he moves closer to fulfilling God’s ultimate plan of salvation, offering us redemption through his selfless love and ultimate sacrifice.
1957 episodes
Manage episode 442741258 series 1319708
In this episode, Dr. John points us to Luke 9:51, where Jesus "set His face to go to Jerusalem." This moment marks a crucial turning point in Jesus' ministry. Even in the face of opposition, Jesus remained steadfast in His journey toward the cross. Dr. John highlights how this decision by Jesus serves as both a challenge and an encouragement for us to remain faithful to God’s calling, even when the road ahead is difficult.
The Unwavering Journey: In this series of messages, Dr. John unpacks Luke 9-13, exploring Jesus’ unwavering journey as He sets his face toward Jerusalem, fully aware of the sacrifice ahead. With every step, he moves closer to fulfilling God’s ultimate plan of salvation, offering us redemption through his selfless love and ultimate sacrifice.
1957 episodes
Tous les épisodes
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.